YOU + California
SUPPORT Prostate Cancer Patients During COVID-19
Virtual Exhibit Hall
Premier Partner: AbbVie
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
At AbbVie, we see a future full of possibility, where health is in reach and patient lives are improved. See our employees, our science and our hope for tomorrow.
Visit Advanced Prostate Cancer Information and Resources
National Partners
Astellas
Pfizer Oncology
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, prostate, kidney, colorectal, blood and lung cancers, as well as melanoma.
Pfizer Oncology's This Is Living With Cancer™ program and the free LivingWith® app
This Is Living With Cancer is a program that includes resources designed for all people living with cancer, regardless of tumor type or stage of disease. This program is available to anyone in the United States, whether they're currently on a Pfizer treatment or not.
An important feature of the program is LivingWith, a free app for people living with cancer and those who love them. LivingWith is designed to help patients connect with loved ones, ask for the help they need, remember important information from doctors' visits and stay organized, all in one place.
LivingWith helps with the small details so patients can focus on the big picture. It's available in English and Spanish.
Website: LivingWith App Website: Know Your Prostate Plan
Bayer
Learn more about a treatment option for prostate cancer that is no longer responding to hormone therapy* and has not spread to other parts of the body.
Learn more about a treatment option for prostate cancer that is no longer responding to hormone therapy* and has spread to the bone with symptoms but not to other parts of the body.
*Hormone therapy includes gonadotropin releasing hormone (GnRH) or surgery that lowers testosterone.
FixIncontinence.com
Contact the Men's Health Patient Education team for more information:
MHpatienteducation@bsci.com or 844-433-2873
EDCure.com
Contact the Men's Health Patient Education team for more information:
MHpatientEducation@bsci.com or 844-433-2873
SpaceOAR Hydrogel
Contact the SpaceOAR Patient Education team for more information:
spaceoarinfo@bsci.com or 508-202-4168
Tolmar
At Tolmar, science drives everything we do. Through a relentless focus on technology, science, partnership and excellence, we seek to advance patient care and deliver value through innovative therapies and services.
Bluechild Entertainment
Bluechild Entertainment is an all-encompassing entertainment entity. Be it film,
television, music or photography production, our products and programming are always
high quality and marketable. Since we are a boutique production company, we are able
to be hands-on in facilitating programming that is unique and original.
We can handle your production for independent commercials, music videos, films, web
series, and television. We can even help you develop and shoot footage for your acting
reel. Every member of our team works professionally in the film and television industry.
We will help you polish your script, put together your crew, edit and score your video
providing you with a polished, professional project.
Bluechild Entertainment is proud to join forces with Edwards Media Group and Jomani
Entertainment to bring a much-needed documentary around prostate cancer to the
screen called, "The Silent Killer". This documentary leaves no stone unturned exposing
this culturally taboo subject and bringing to light the deadly consequences of avoiding
exams. The men profiled in the film have from stage 1 to stage 4 prostate cancer. They
candidly discuss their fears, concerns, and myths surrounding their prostate health,
exams and what it means to change their lifestyle in order to live.
Learn more about this film and this important message here: https://www.silentkillerdoc.com/
Platinum Partners
Northrop Grumman
We are committed to advancing global security and human discovery in support of our customers’ missions around the world. We do so by providing leading technology and national security solutions and services to markets around the world. Northrop Grumman has approximately 90,000 employees with more than 550 facilities in all 50 U.S. states and in more than 25 countries around the world. To find out more about our job locations, click here. Northrop Grumman continues to expand and broaden our presence in global markets and strengthen our partnerships with local industry. Our focus countries are Australia, the United Kingdom, Japan, South Korea and the Middle East. To find out more about our global presence, click here. Find out the latest developments about Northrop Grumman on our news site. Sign up for automatic alerts and check out our video galleries. Go to News.
Visit Our Website
Dendreon
Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of treatments that harness the power of the immune system to extend life. Dendreon’s flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. Nearly 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. For more information, please visit www.provenge.com.
Visit Our Website
Gold Partners
Amgen
Amgen is a worldwide pioneer in biotechnology. Our mission is to serve patients. We are proud of our heritage as a biotech startup, our people, our culture, our dedication to our mission and always doing the right thing in everything we do through corporate responsibility it’s what makes Amgen a great and special place to work. Together, we transform how patients, physicians, caregivers and societies around the world fight serious illnesses and high unmet medical need. We discover, develop and deliver transformative medicines that address the leading causes of death and disability and we find new solutions to meet the growing demand for better quality healthcare for more people worldwide.
Visit Our Website
Halo Diagnostics
HALO Diagnostics is a very different kind of healthcare company. Headquartered in Silicon Valley, CA, HALO Diagnostics leverages cutting-edge artificial intelligence and machine learning, along with the latest in advanced imaging and diagnostic biomarkers to deliver more holistic diagnostic insights and significant improvement in patient experience and outcomes.
Thanks to advances in technology, many of today’s most devastating diseases can be diagnosed earlier and more accurately, and then treated less invasively and without surgery. HALO Diagnostics believes that advanced technology can help deliver a better patient experience with a more personalized touch. At the core of the practice is an array of advanced imaging technologies—used to both diagnose disease and guide treatment. Early detection of disease enables a broader assortment of treatment options, and HALO offers several minimally invasive therapies that are just as effective as traditional surgery, with less risk and a shorter recovery period.
The specialized team at HALO Diagnostics have pioneered a new approach to prostate cancer treatment, Laser Focal Therapy. HALO recently released interim 10-year results from its Phase II 20-year clinical trial for prostate laser focal therapy in patients with localized prostate cancer. The results are impressive: less than 1% infection, less than 1% erectile dysfunction and less than 1% incontinence. These results, along with a 100% prostate cancer-specific survival rate, are an encouraging development for men looking for a prostate cancer therapy option with a lower risk of side effects.
The prostate program is just one step in helping fulfill HALO Diagnostics’ mission of improving human health and well-being via local and easy access to advanced diagnostics and image-guided therapy options. For more information visit www.halodx.com and follow LinkedIn and Facebook to stay up to date with all things HALO Dx.
